ASBP
Aspire BioPharma, Inc.
NASDAQ: ASBP · HEALTHCARE · BIOTECHNOLOGY
$0.22
-9.30% today
Updated 2026-04-30
Market cap
$1.03M
P/E ratio
—
P/S ratio
166.07x
EPS (TTM)
$-16.38
Dividend yield
—
52W range
$0 – $35
Volume
12.1M
Aspire BioPharma, Inc. (ASBP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |